Your Location：
Home >
Browse articles >
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
RESEARCH | Updated：2023-09-05
Previous|Next

    • Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial

    • Ming-Huan Zhu , Zhen-Jing Liu , Qiong-Yue Hu , Jia-Yu Yang , Ying Jin , Na Zhu , Ying Huang , Dian-Hong Shi , Min-Jia Liu , Hong-Yang Tan , Lei Zhao , Qin-Yu Lv , Zheng-Hui Yi , Feng-Chun Wu , Ze-Zhi Li
    • Military Medical Research Vol. 10, Issue 4, Pages: 431-443(2023)

    • DOI： 10.1186/s40779-022-00420-0     

      CLC：

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Figs( 4 ) Tabs( 3 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

51

Views

15

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance

Related Author

Zhe-Wei Kang
Yun-Dan Liao
Jun Li
Tian-Lan Lu
Hao Yan
Xiao Xiao
Yong-Feng Yang
Wen-Qiang Li

Related Institution

Institute of Mental Health, Peking University Sixth Hospital
Chinese Institute for Brain Research
National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital
NHC Key Laboratory of Mental Health and Research Unit of Diagnosis and Treatment of Mood Cognitive Disorder (2018RU006), Chinese Academy of Medical Sciences
Peking University Huilongguan Clinical Medical School, Beijing Huilongguan Hospital